Cargando…

Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics

SIMPLE SUMMARY: Gastric cancer (GC) is common but often diagnosed late. Recent advances in chemotherapy, targeted therapy, and immunotherapy offer promising treatments. Perioperative chemotherapy is now the standard for resectable gastric cancer. Progress has also been made in treating metastatic di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baccili Cury Megid, Thais, Farooq, Abdul Rehman, Wang, Xin, Elimova, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605200/ https://www.ncbi.nlm.nih.gov/pubmed/37894443 http://dx.doi.org/10.3390/cancers15205075

Ejemplares similares

Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
por: Megid, Thais Baccili Cury, et al.
Publicado: (2022)

Response to anti-PD1 immunotherapy in patients with metastatic cutaneous sarcoma: case reports and literature review
por: Vieira, Aline Cristini, et al.
Publicado: (2020)

Targeting gamma delta T cells for cancer immunotherapy: bench to bedside
por: Gogoi, Dimpu, et al.
Publicado: (2013)

Novel Therapeutic Targets in Metabolic Disorders: From the Bench to the Bedside
por: Illario, Maddalena, et al.
Publicado: (2014)

Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer
por: Li, Difeng, et al.
Publicado: (2022)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
por: Wang, Ya-Tao, et al.
Publicado: (2022)

Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
por: Casimiro, Sandra, et al.
Publicado: (2016)

From Bench to Bedside: Immunotherapy for Prostate Cancer
por: Tse, Brian Wan-Chi, et al.
Publicado: (2014)

Cancer photo-immunotherapy: from bench to bedside
por: Wang, Miao, et al.
Publicado: (2021)

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench
por: Subbiah, Vivek, et al.
Publicado: (2022)

Immunotherapy for Recurrent Glioma—From Bench to Bedside
por: Pu, Yi, et al.
Publicado: (2023)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets—From Bench to Bed Site
por: Gajecki, Damian, et al.
Publicado: (2020)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020)

Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
por: Tristán-Manzano, María, et al.
Publicado: (2020)

Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside
por: Xie, Fei, et al.
Publicado: (2023)

Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
por: Li, Ying Hong, et al.
Publicado: (2018)

KCNE2 and gastric cancer: bench to bedside
por: Abbott, Geoffrey W., et al.
Publicado: (2016)

Editorial: Novel therapeutic strategies for chronic kidney disease: from bench to bedside
por: Huang, Chunling, et al.
Publicado: (2023)

CAR-NK cells for cancer immunotherapy: from bench to bedside
por: Zhang, Leisheng, et al.
Publicado: (2022)

Digital therapeutics from bench to bedside
por: Wang, Changwon, et al.
Publicado: (2023)

Lung Mechanics Over the Century: From Bench to Bedside and Back to Bench
por: Biselli, Paolo Jose Cesare, et al.
Publicado: (2022)

Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside
por: Hebert, Jessica F., et al.
Publicado: (2022)

Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer
por: Kang, Donghoon, et al.
Publicado: (2022)

Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside
por: Squatrito, D., et al.
Publicado: (2014)

Bedside to bench and back to bedside: Translational implications of targeted intervertebral disc therapeutics
por: Rosenberg, Gary Joel, et al.
Publicado: (2017)

Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance
por: Wagstaff, William, et al.
Publicado: (2022)

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
por: Zoja, Carlamaria, et al.
Publicado: (2020)

Potential of Bioactive Food Components against Gastric Cancer: Insights into Molecular Mechanism and Therapeutic Targets
por: Kang, Seog Young, et al.
Publicado: (2021)

Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
por: Ahmed, Md. Selim, et al.
Publicado: (2016)

From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
por: Kunk, Paul R., et al.
Publicado: (2016)

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside
por: Saburi, Ehsan, et al.
Publicado: (2017)

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022)

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
por: Salah, Ahmed, et al.
Publicado: (2021)

Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed
por: Hu, Xiaoyi, et al.
Publicado: (2022)

Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
por: Wang, Ding-Kang, et al.
Publicado: (2021)

The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets
por: Yao, Yizheng, et al.
Publicado: (2017)

Molecular Imaging: From Bench to Clinic
por: Wáng, Yì-Xiáng J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g138v9ka5kehlo7e6qucrl4acm